Although CAP measured by Fibroscan could evaluate the degree of hepatic steatosis in CHB patients34–36, few biomarkers could specifically diagnose NASH in such patients due to the disturbance possibly by HBV related elevation of ALT and the inflammatory status. Here, GPT is linked to fatty liver disease.